The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study

Health and Quality of Life Outcomes

Volumn 2, Issue , 2004, Pages

  Heinemann, Lothar A J ^a   DoMinh, Thai ^a   Strelow, Frank ^b   Gerbsch, Silvia ^b   Schnitker, Jörg ^c   Schneider, Hermann P G ^d  

^a Berlin Center for Epidemiology and Health Research   (Germany)

^b BAYER PHARMA AG   (Germany)

^c Inst für Angewandte Statistik   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Health related quality of life; Hormone treatment; Menopause; MRS; Questionnaire; Validity

Indexed keywords

CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; CYPROTERONE ACETATE; DRUG DERIVATIVE; ESTRADIOL; ESTRADIOL VALERATE, CYPROTERONE ACETATE DRUG COMBINATION;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENOPAUSAL SYNDROME; MENOPAUSE; METHODOLOGY; OUTCOMES RESEARCH; PHYSICIAN ATTITUDE; POSTMARKETING SURVEILLANCE; PREDICTION; QUALITY OF LIFE; RATING SCALE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; GERMANY; GYNECOLOGY; HORMONE SUBSTITUTION; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; UROGENITAL TRACT DISEASE; VALIDATION STUDY; WOMEN'S HEALTH;

ADULT; CYPROTERONE ACETATE; DRUG COMBINATIONS; ESTRADIOL; FEMALE; FEMALE UROGENITAL DISEASES; GERMANY; GYNECOLOGY; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PRODUCT SURVEILLANCE, POSTMARKETING; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 16344382540     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-2-67     Document Type: Article

References (12)

1. Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HPG: Evaluation der klinischen Beschwerden (Menopause Rating Scale). Zentralbl Gynakol 1994, 116:16-23.
2. Potthoff P, Heinemann LAJ, Schneider HPG, Rosemeier HP, Hauser GA: Menopause-Rating Skala (MRS): Methodische Standardisierung in der deutschen Bevölkerung. Zentralbl Gynakol 2000, 122: 80-286.
3. Heinemann K, Assmann A, Möhner S, Schneider HPG, Heinemann LAJ: Reliabilität der Menopause-Rating-Skala (MRS). Untersuchung für dieDeutsche Bevölkerung. Zentralbl Gynakol 2002, 124:161-163.
4. Schneider HPG, Heinemann LAJ, Rosemeier HP, Potthoff P, Behre HM: The Menopause Rating Scale (MRS): Reliability of scores of menopausal complaints. Climacteric 2000, 3:59-64.
5. Schneider HPG, Heinemann LAJ, Rosemeier HP, Potthoff P, Behre HM: The Menopause Rating Scale (MRS): Comparison with Kupperman Index and Quality of Life Scale SF-36. Climacteric 2000, 3: 0-58.
6. Schneider HPG, Rosemeier HP, Schnitker J, Gerbsch S, Turck R: Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen®. Maturitas 2000, 37:113-124.
7. Schneider HPG, Heinemann LAJ, Thiele K: The Menopause Rating Scale (MRS): Cultural and linguistic translation into English. Life and Medical Science Online 2002, 3:. DOI:10.1072/LO0305326
8. Heinemann LAJ, Potthoff P, Schneider HPG: International versions of the Menopause Rating Scale (MRS).Health Qual Life Outcomes 2003, 1:28.
9. Heinemann K, Ruebig A, Potthoff P, Schneider HPG, Strelow F, Heinemann LAJ, Do Minh T: The Menopause Rating Scale (MRS) scale: A methodological review. Health Qual Life Outcomes 2004, 2: 5.
10. Anonymous: Trust introduces new translation criteria. Medical Outcomes Trust Bulletin 1997, 5:2-4.
11. Acquadro C, Jambon B, Ellis D, Marquis P: Languages and translation issues. Quality of Life and Pharmaco-Econonomics in Clinical Trials 21996:575-585.
12. Greene JG: Measuring the symptom dimension of quality of life: General and menopause-specific scales and their subscale structure. In In: Hormone replacement therapy and quality of life. The Parthenon Publishing Group Edited by: Schneider HPG. Boca Raton, London, New York, Washington; 2002:35-43.